nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR0B1—Vincristine—lymphatic system cancer	0.271	0.331	CbGbCtD
Dexamethasone—CYP1B1—Mitoxantrone—lymphatic system cancer	0.0785	0.0958	CbGbCtD
Dexamethasone—ABCB11—Vincristine—lymphatic system cancer	0.054	0.066	CbGbCtD
Dexamethasone—ABCG2—Teniposide—lymphatic system cancer	0.0534	0.0651	CbGbCtD
Dexamethasone—ABCG2—Mitoxantrone—lymphatic system cancer	0.0373	0.0456	CbGbCtD
Dexamethasone—CYP3A5—Teniposide—lymphatic system cancer	0.0296	0.0361	CbGbCtD
Dexamethasone—ABCC2—Vincristine—lymphatic system cancer	0.0284	0.0347	CbGbCtD
Dexamethasone—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0266	0.0325	CbGbCtD
Dexamethasone—ABCG2—Vincristine—lymphatic system cancer	0.0257	0.0314	CbGbCtD
Dexamethasone—CYP2C19—Teniposide—lymphatic system cancer	0.0238	0.0291	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—lymphatic system cancer	0.0207	0.0253	CbGbCtD
Dexamethasone—CYP2C9—Teniposide—lymphatic system cancer	0.0198	0.0242	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—lymphatic system cancer	0.019	0.0232	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.019	0.0232	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—lymphatic system cancer	0.0172	0.021	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—lymphatic system cancer	0.0156	0.019	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—lymphatic system cancer	0.0142	0.0174	CbGbCtD
Dexamethasone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0135	0.0164	CbGbCtD
Dexamethasone—CYP3A4—Cytarabine—lymphatic system cancer	0.0117	0.0143	CbGbCtD
Dexamethasone—CYP3A4—Teniposide—lymphatic system cancer	0.0115	0.0141	CbGbCtD
Dexamethasone—ABCB1—Vincristine—lymphatic system cancer	0.00926	0.0113	CbGbCtD
Dexamethasone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00806	0.00984	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—lymphatic system cancer	0.00561	0.00685	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—lymphatic system cancer	0.00555	0.00677	CbGbCtD
Dexamethasone—Haemorrhage—Bleomycin—lymphatic system cancer	0.000384	0.00212	CcSEcCtD
Dexamethasone—Discomfort—Fludarabine—lymphatic system cancer	0.000384	0.00212	CcSEcCtD
Dexamethasone—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000379	0.0021	CcSEcCtD
Dexamethasone—Hyperglycaemia—Carmustine—lymphatic system cancer	0.000378	0.00209	CcSEcCtD
Dexamethasone—Petechiae—Methotrexate—lymphatic system cancer	0.000376	0.00208	CcSEcCtD
Dexamethasone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000372	0.00206	CcSEcCtD
Dexamethasone—Oedema—Fludarabine—lymphatic system cancer	0.000372	0.00206	CcSEcCtD
Dexamethasone—Infection—Fludarabine—lymphatic system cancer	0.00037	0.00204	CcSEcCtD
Dexamethasone—Decreased appetite—Teniposide—lymphatic system cancer	0.000368	0.00204	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000366	0.00202	CcSEcCtD
Dexamethasone—Vomiting—Mechlorethamine—lymphatic system cancer	0.000365	0.00202	CcSEcCtD
Dexamethasone—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000365	0.00202	CcSEcCtD
Dexamethasone—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000364	0.00201	CcSEcCtD
Dexamethasone—Rash—Mechlorethamine—lymphatic system cancer	0.000362	0.002	CcSEcCtD
Dexamethasone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000362	0.002	CcSEcCtD
Dexamethasone—Weight decreased—Vincristine—lymphatic system cancer	0.000362	0.002	CcSEcCtD
Dexamethasone—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00036	0.00199	CcSEcCtD
Dexamethasone—Anorexia—Fludarabine—lymphatic system cancer	0.000355	0.00196	CcSEcCtD
Dexamethasone—Extravasation—Methotrexate—lymphatic system cancer	0.000354	0.00196	CcSEcCtD
Dexamethasone—Weight increased—Mitoxantrone—lymphatic system cancer	0.000354	0.00196	CcSEcCtD
Dexamethasone—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000352	0.00195	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000351	0.00194	CcSEcCtD
Dexamethasone—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000351	0.00194	CcSEcCtD
Dexamethasone—Myocardial infarction—Vincristine—lymphatic system cancer	0.000349	0.00193	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000349	0.00193	CcSEcCtD
Dexamethasone—Feeling abnormal—Teniposide—lymphatic system cancer	0.000349	0.00193	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000346	0.00191	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000342	0.00189	CcSEcCtD
Dexamethasone—Nausea—Mechlorethamine—lymphatic system cancer	0.000341	0.00189	CcSEcCtD
Dexamethasone—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00034	0.00188	CcSEcCtD
Dexamethasone—Alopecia—Bleomycin—lymphatic system cancer	0.000339	0.00188	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000339	0.00187	CcSEcCtD
Dexamethasone—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000337	0.00187	CcSEcCtD
Dexamethasone—Haemoglobin—Carmustine—lymphatic system cancer	0.000337	0.00186	CcSEcCtD
Dexamethasone—Urticaria—Teniposide—lymphatic system cancer	0.000336	0.00186	CcSEcCtD
Dexamethasone—Herpes simplex—Methotrexate—lymphatic system cancer	0.000336	0.00186	CcSEcCtD
Dexamethasone—Haemorrhage—Carmustine—lymphatic system cancer	0.000335	0.00185	CcSEcCtD
Dexamethasone—Body temperature increased—Teniposide—lymphatic system cancer	0.000335	0.00185	CcSEcCtD
Dexamethasone—Abdominal pain—Teniposide—lymphatic system cancer	0.000335	0.00185	CcSEcCtD
Dexamethasone—Erythema—Bleomycin—lymphatic system cancer	0.000334	0.00185	CcSEcCtD
Dexamethasone—Paraesthesia—Fludarabine—lymphatic system cancer	0.000334	0.00185	CcSEcCtD
Dexamethasone—Hallucination—Carmustine—lymphatic system cancer	0.000334	0.00184	CcSEcCtD
Dexamethasone—Dyspepsia—Fludarabine—lymphatic system cancer	0.000328	0.00181	CcSEcCtD
Dexamethasone—Ulcer—Methotrexate—lymphatic system cancer	0.000327	0.00181	CcSEcCtD
Dexamethasone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000323	0.00179	CcSEcCtD
Dexamethasone—Visual impairment—Carmustine—lymphatic system cancer	0.000323	0.00179	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000321	0.00178	CcSEcCtD
Dexamethasone—Fatigue—Fludarabine—lymphatic system cancer	0.000321	0.00177	CcSEcCtD
Dexamethasone—Hallucination—Vincristine—lymphatic system cancer	0.000318	0.00176	CcSEcCtD
Dexamethasone—Pain—Fludarabine—lymphatic system cancer	0.000318	0.00176	CcSEcCtD
Dexamethasone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000317	0.00175	CcSEcCtD
Dexamethasone—Vasculitis—Methotrexate—lymphatic system cancer	0.000317	0.00175	CcSEcCtD
Dexamethasone—Eye disorder—Carmustine—lymphatic system cancer	0.000313	0.00173	CcSEcCtD
Dexamethasone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000313	0.00173	CcSEcCtD
Dexamethasone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000312	0.00172	CcSEcCtD
Dexamethasone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00031	0.00172	CcSEcCtD
Dexamethasone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000307	0.0017	CcSEcCtD
Dexamethasone—Asthenia—Teniposide—lymphatic system cancer	0.000304	0.00168	CcSEcCtD
Dexamethasone—Malaise—Bleomycin—lymphatic system cancer	0.000301	0.00167	CcSEcCtD
Dexamethasone—Pruritus—Teniposide—lymphatic system cancer	0.0003	0.00166	CcSEcCtD
Dexamethasone—Arrhythmia—Carmustine—lymphatic system cancer	0.000299	0.00166	CcSEcCtD
Dexamethasone—Alopecia—Carmustine—lymphatic system cancer	0.000296	0.00164	CcSEcCtD
Dexamethasone—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000295	0.00163	CcSEcCtD
Dexamethasone—Body temperature increased—Fludarabine—lymphatic system cancer	0.000294	0.00163	CcSEcCtD
Dexamethasone—Erythema—Carmustine—lymphatic system cancer	0.000292	0.00161	CcSEcCtD
Dexamethasone—Angiopathy—Vincristine—lymphatic system cancer	0.00029	0.00161	CcSEcCtD
Dexamethasone—Diarrhoea—Teniposide—lymphatic system cancer	0.00029	0.0016	CcSEcCtD
Dexamethasone—Myalgia—Bleomycin—lymphatic system cancer	0.000285	0.00157	CcSEcCtD
Dexamethasone—Alopecia—Vincristine—lymphatic system cancer	0.000283	0.00156	CcSEcCtD
Dexamethasone—Discomfort—Bleomycin—lymphatic system cancer	0.000281	0.00155	CcSEcCtD
Dexamethasone—Ecchymosis—Methotrexate—lymphatic system cancer	0.00028	0.00155	CcSEcCtD
Dexamethasone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000278	0.00154	CcSEcCtD
Dexamethasone—Alopecia—Mitoxantrone—lymphatic system cancer	0.000275	0.00152	CcSEcCtD
Dexamethasone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000275	0.00152	CcSEcCtD
Dexamethasone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000273	0.00151	CcSEcCtD
Dexamethasone—Oedema—Bleomycin—lymphatic system cancer	0.000273	0.00151	CcSEcCtD
Dexamethasone—Erythema—Mitoxantrone—lymphatic system cancer	0.000271	0.0015	CcSEcCtD
Dexamethasone—Infection—Bleomycin—lymphatic system cancer	0.000271	0.0015	CcSEcCtD
Dexamethasone—Vomiting—Teniposide—lymphatic system cancer	0.000269	0.00149	CcSEcCtD
Dexamethasone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000267	0.00148	CcSEcCtD
Dexamethasone—Asthenia—Fludarabine—lymphatic system cancer	0.000267	0.00148	CcSEcCtD
Dexamethasone—Rash—Teniposide—lymphatic system cancer	0.000267	0.00148	CcSEcCtD
Dexamethasone—Dermatitis—Teniposide—lymphatic system cancer	0.000267	0.00147	CcSEcCtD
Dexamethasone—Headache—Teniposide—lymphatic system cancer	0.000265	0.00147	CcSEcCtD
Dexamethasone—Pruritus—Fludarabine—lymphatic system cancer	0.000263	0.00146	CcSEcCtD
Dexamethasone—Anorexia—Bleomycin—lymphatic system cancer	0.00026	0.00144	CcSEcCtD
Dexamethasone—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000259	0.00143	CcSEcCtD
Dexamethasone—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000258	0.00143	CcSEcCtD
Dexamethasone—Hypotension—Bleomycin—lymphatic system cancer	0.000255	0.00141	CcSEcCtD
Dexamethasone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000255	0.00141	CcSEcCtD
Dexamethasone—Convulsion—Carmustine—lymphatic system cancer	0.000253	0.0014	CcSEcCtD
Dexamethasone—Hypertension—Carmustine—lymphatic system cancer	0.000252	0.00139	CcSEcCtD
Dexamethasone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000252	0.00139	CcSEcCtD
Dexamethasone—Nausea—Teniposide—lymphatic system cancer	0.000252	0.00139	CcSEcCtD
Dexamethasone—Vertigo—Vincristine—lymphatic system cancer	0.00025	0.00138	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000249	0.00137	CcSEcCtD
Dexamethasone—Myalgia—Carmustine—lymphatic system cancer	0.000248	0.00137	CcSEcCtD
Dexamethasone—Anxiety—Carmustine—lymphatic system cancer	0.000248	0.00137	CcSEcCtD
Dexamethasone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000245	0.00135	CcSEcCtD
Dexamethasone—Malaise—Mitoxantrone—lymphatic system cancer	0.000245	0.00135	CcSEcCtD
Dexamethasone—Convulsion—Vincristine—lymphatic system cancer	0.000241	0.00133	CcSEcCtD
Dexamethasone—Hypertension—Vincristine—lymphatic system cancer	0.000241	0.00133	CcSEcCtD
Dexamethasone—Oedema—Carmustine—lymphatic system cancer	0.000238	0.00132	CcSEcCtD
Dexamethasone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000237	0.00131	CcSEcCtD
Dexamethasone—Myalgia—Vincristine—lymphatic system cancer	0.000237	0.00131	CcSEcCtD
Dexamethasone—Visual disturbance—Methotrexate—lymphatic system cancer	0.000237	0.00131	CcSEcCtD
Dexamethasone—Infection—Carmustine—lymphatic system cancer	0.000237	0.00131	CcSEcCtD
Dexamethasone—Vomiting—Fludarabine—lymphatic system cancer	0.000237	0.00131	CcSEcCtD
Dexamethasone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000235	0.0013	CcSEcCtD
Dexamethasone—Rash—Fludarabine—lymphatic system cancer	0.000235	0.0013	CcSEcCtD
Dexamethasone—Dermatitis—Fludarabine—lymphatic system cancer	0.000234	0.0013	CcSEcCtD
Dexamethasone—Hypertension—Mitoxantrone—lymphatic system cancer	0.000234	0.0013	CcSEcCtD
Dexamethasone—Pain—Bleomycin—lymphatic system cancer	0.000233	0.00129	CcSEcCtD
Dexamethasone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000233	0.00129	CcSEcCtD
Dexamethasone—Headache—Fludarabine—lymphatic system cancer	0.000233	0.00129	CcSEcCtD
Dexamethasone—Tachycardia—Carmustine—lymphatic system cancer	0.000232	0.00129	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000232	0.00128	CcSEcCtD
Dexamethasone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000231	0.00128	CcSEcCtD
Dexamethasone—Anxiety—Mitoxantrone—lymphatic system cancer	0.00023	0.00127	CcSEcCtD
Dexamethasone—Lethargy—Methotrexate—lymphatic system cancer	0.000229	0.00127	CcSEcCtD
Dexamethasone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000228	0.00126	CcSEcCtD
Dexamethasone—Oedema—Vincristine—lymphatic system cancer	0.000227	0.00126	CcSEcCtD
Dexamethasone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000227	0.00126	CcSEcCtD
Dexamethasone—Anorexia—Carmustine—lymphatic system cancer	0.000227	0.00126	CcSEcCtD
Dexamethasone—Infection—Vincristine—lymphatic system cancer	0.000226	0.00125	CcSEcCtD
Dexamethasone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000225	0.00124	CcSEcCtD
Dexamethasone—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000224	0.00124	CcSEcCtD
Dexamethasone—Nervous system disorder—Vincristine—lymphatic system cancer	0.000223	0.00123	CcSEcCtD
Dexamethasone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000223	0.00123	CcSEcCtD
Dexamethasone—Hypotension—Carmustine—lymphatic system cancer	0.000223	0.00123	CcSEcCtD
Dexamethasone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000221	0.00122	CcSEcCtD
Dexamethasone—Oedema—Mitoxantrone—lymphatic system cancer	0.000221	0.00122	CcSEcCtD
Dexamethasone—Nausea—Fludarabine—lymphatic system cancer	0.000221	0.00122	CcSEcCtD
Dexamethasone—Infection—Mitoxantrone—lymphatic system cancer	0.00022	0.00122	CcSEcCtD
Dexamethasone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00022	0.00122	CcSEcCtD
Dexamethasone—Shock—Mitoxantrone—lymphatic system cancer	0.000218	0.0012	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000217	0.0012	CcSEcCtD
Dexamethasone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000217	0.0012	CcSEcCtD
Dexamethasone—Urticaria—Bleomycin—lymphatic system cancer	0.000217	0.0012	CcSEcCtD
Dexamethasone—Anorexia—Vincristine—lymphatic system cancer	0.000217	0.0012	CcSEcCtD
Dexamethasone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000216	0.00119	CcSEcCtD
Dexamethasone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000216	0.00119	CcSEcCtD
Dexamethasone—Insomnia—Carmustine—lymphatic system cancer	0.000215	0.00119	CcSEcCtD
Dexamethasone—Irritability—Methotrexate—lymphatic system cancer	0.000214	0.00118	CcSEcCtD
Dexamethasone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000214	0.00118	CcSEcCtD
Dexamethasone—Paraesthesia—Carmustine—lymphatic system cancer	0.000214	0.00118	CcSEcCtD
Dexamethasone—Mood swings—Methotrexate—lymphatic system cancer	0.000213	0.00118	CcSEcCtD
Dexamethasone—Hypotension—Vincristine—lymphatic system cancer	0.000212	0.00117	CcSEcCtD
Dexamethasone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000211	0.00117	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000207	0.00115	CcSEcCtD
Dexamethasone—Decreased appetite—Carmustine—lymphatic system cancer	0.000207	0.00114	CcSEcCtD
Dexamethasone—Hypotension—Mitoxantrone—lymphatic system cancer	0.000207	0.00114	CcSEcCtD
Dexamethasone—Insomnia—Vincristine—lymphatic system cancer	0.000206	0.00114	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000206	0.00114	CcSEcCtD
Dexamethasone—Paraesthesia—Vincristine—lymphatic system cancer	0.000204	0.00113	CcSEcCtD
Dexamethasone—Pain—Carmustine—lymphatic system cancer	0.000204	0.00113	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000202	0.00112	CcSEcCtD
Dexamethasone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000199	0.0011	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—lymphatic system cancer	0.000198	0.00109	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000196	0.00109	CcSEcCtD
Dexamethasone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000196	0.00109	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—lymphatic system cancer	0.000196	0.00108	CcSEcCtD
Dexamethasone—Asthenia—Bleomycin—lymphatic system cancer	0.000196	0.00108	CcSEcCtD
Dexamethasone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000195	0.00108	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000195	0.00108	CcSEcCtD
Dexamethasone—Pain—Vincristine—lymphatic system cancer	0.000194	0.00108	CcSEcCtD
Dexamethasone—Pruritus—Bleomycin—lymphatic system cancer	0.000193	0.00107	CcSEcCtD
Dexamethasone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000192	0.00106	CcSEcCtD
Dexamethasone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000191	0.00106	CcSEcCtD
Dexamethasone—Pain—Mitoxantrone—lymphatic system cancer	0.000189	0.00105	CcSEcCtD
Dexamethasone—Abdominal pain—Carmustine—lymphatic system cancer	0.000188	0.00104	CcSEcCtD
Dexamethasone—Body temperature increased—Carmustine—lymphatic system cancer	0.000188	0.00104	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000186	0.00103	CcSEcCtD
Dexamethasone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000182	0.00101	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000181	0.001	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—lymphatic system cancer	0.00018	0.000994	CcSEcCtD
Dexamethasone—Body temperature increased—Vincristine—lymphatic system cancer	0.00018	0.000994	CcSEcCtD
Dexamethasone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000176	0.000973	CcSEcCtD
Dexamethasone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000175	0.000968	CcSEcCtD
Dexamethasone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000175	0.000968	CcSEcCtD
Dexamethasone—Vomiting—Bleomycin—lymphatic system cancer	0.000173	0.000959	CcSEcCtD
Dexamethasone—Rash—Bleomycin—lymphatic system cancer	0.000172	0.000951	CcSEcCtD
Dexamethasone—Dermatitis—Bleomycin—lymphatic system cancer	0.000172	0.00095	CcSEcCtD
Dexamethasone—Asthenia—Carmustine—lymphatic system cancer	0.000171	0.000945	CcSEcCtD
Dexamethasone—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000168	0.00093	CcSEcCtD
Dexamethasone—Asthenia—Vincristine—lymphatic system cancer	0.000163	0.000902	CcSEcCtD
Dexamethasone—Diarrhoea—Carmustine—lymphatic system cancer	0.000163	0.000901	CcSEcCtD
Dexamethasone—Nausea—Bleomycin—lymphatic system cancer	0.000162	0.000896	CcSEcCtD
Dexamethasone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000159	0.000878	CcSEcCtD
Dexamethasone—Dizziness—Carmustine—lymphatic system cancer	0.000157	0.000871	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000156	0.000863	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—lymphatic system cancer	0.000156	0.00086	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000155	0.000859	CcSEcCtD
Dexamethasone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000151	0.000838	CcSEcCtD
Dexamethasone—Vomiting—Carmustine—lymphatic system cancer	0.000151	0.000837	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—lymphatic system cancer	0.00015	0.000831	CcSEcCtD
Dexamethasone—Rash—Carmustine—lymphatic system cancer	0.00015	0.00083	CcSEcCtD
Dexamethasone—Dermatitis—Carmustine—lymphatic system cancer	0.00015	0.00083	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—lymphatic system cancer	0.00015	0.000827	CcSEcCtD
Dexamethasone—Headache—Carmustine—lymphatic system cancer	0.000149	0.000825	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—lymphatic system cancer	0.000145	0.000802	CcSEcCtD
Dexamethasone—Vomiting—Vincristine—lymphatic system cancer	0.000145	0.000799	CcSEcCtD
Dexamethasone—Rash—Vincristine—lymphatic system cancer	0.000143	0.000793	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—lymphatic system cancer	0.000143	0.000792	CcSEcCtD
Dexamethasone—Headache—Vincristine—lymphatic system cancer	0.000142	0.000788	CcSEcCtD
Dexamethasone—Nausea—Carmustine—lymphatic system cancer	0.000141	0.000782	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—lymphatic system cancer	0.000141	0.000779	CcSEcCtD
Dexamethasone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000141	0.000778	CcSEcCtD
Dexamethasone—Rash—Mitoxantrone—lymphatic system cancer	0.00014	0.000772	CcSEcCtD
Dexamethasone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000139	0.000771	CcSEcCtD
Dexamethasone—Headache—Mitoxantrone—lymphatic system cancer	0.000139	0.000767	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—lymphatic system cancer	0.000137	0.000759	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—lymphatic system cancer	0.000135	0.000747	CcSEcCtD
Dexamethasone—Nausea—Vincristine—lymphatic system cancer	0.000135	0.000747	CcSEcCtD
Dexamethasone—Nausea—Mitoxantrone—lymphatic system cancer	0.000132	0.000727	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000125	0.000693	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—lymphatic system cancer	0.000122	0.000674	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—lymphatic system cancer	0.000121	0.000671	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—lymphatic system cancer	0.000117	0.000648	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—lymphatic system cancer	0.000115	0.000636	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—lymphatic system cancer	0.000114	0.000629	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00011	0.00061	CcSEcCtD
Dexamethasone—Infection—Methotrexate—lymphatic system cancer	0.00011	0.000606	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000108	0.000598	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000108	0.000597	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000107	0.00059	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—lymphatic system cancer	0.000105	0.000581	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—lymphatic system cancer	0.000103	0.00057	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000101	0.000556	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—lymphatic system cancer	9.98e-05	0.000552	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—lymphatic system cancer	9.91e-05	0.000548	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—lymphatic system cancer	9.71e-05	0.000537	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—lymphatic system cancer	9.59e-05	0.00053	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	9.52e-05	0.000527	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—lymphatic system cancer	9.51e-05	0.000526	CcSEcCtD
Dexamethasone—Pain—Methotrexate—lymphatic system cancer	9.43e-05	0.000522	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—lymphatic system cancer	9.09e-05	0.000503	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	9.02e-05	0.000499	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—lymphatic system cancer	8.76e-05	0.000485	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—lymphatic system cancer	8.72e-05	0.000482	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—lymphatic system cancer	8.72e-05	0.000482	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—lymphatic system cancer	7.91e-05	0.000438	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—lymphatic system cancer	7.8e-05	0.000432	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—lymphatic system cancer	7.55e-05	0.000417	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—lymphatic system cancer	7.3e-05	0.000403	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—lymphatic system cancer	7.01e-05	0.000388	CcSEcCtD
Dexamethasone—Rash—Methotrexate—lymphatic system cancer	6.96e-05	0.000385	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—lymphatic system cancer	6.95e-05	0.000384	CcSEcCtD
Dexamethasone—Headache—Methotrexate—lymphatic system cancer	6.91e-05	0.000382	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—lymphatic system cancer	6.55e-05	0.000362	CcSEcCtD
